Vanda Pharmaceuticals
VNDA
#7727
Rank
A$0.44 B
Marketcap
$7.61
Share price
-0.21%
Change (1 day)
28.61%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2024 (TTM): -A$61.76 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.19 Billion. a decrease over its 2023 earnings that were of -A$22.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 -A$64.35 Million191.43%
2023 -A$22.08 Million-320.45%
2022 A$10.01 M-84.99%
2021 A$66.72 M54.8%
2020 A$43.1 M19.42%
2019 A$36.09 M4.93%
2018 A$34.39 M-228.6%
2017 -A$26.75 Million-8.98%
2016 -A$29.39 Million-53.79%
2015 -A$63.6 Million-30.18%
2014 -A$91.08 Million173.08%
2013 -A$33.36 Million-25.33%
2012 -A$44.67 Million163.61%
2011 -A$16.95 Million-221.15%
2010 A$13.98 M-124.53%
2009 -A$57.02 Million-29.44%
2008 -A$80.81 Million-36.2%
2007 -A$0.13 Billion21.81%
2006 -A$0.11 Billion170.55%
2005 -A$38.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$21.58 B-33,646.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$20.06 B-31,286.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.60 B-42,997.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.26 Billion 20,507.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.58 B-27,431.53%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$9.32 Million-85.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$33.55 B-52,256.91%๐Ÿ‡บ๐Ÿ‡ธ USA